Visiongain Publishes Population Health Management Market Report 2020-2030

30 July 2020
Pharma

Visiongain has launched a new report Population Health Management Market Report 2020-2030: Forecasts by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End-user (Healthcare Providers, Healthcare Payers, Others), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

Population health management is a collection of patient data that has been obtained from various resources. It is used to monitor the patient condition and categorize them based on the common medical conditions and attributes. The collection and analysis of patient data helps to healthcare providers enhance the financial and clinical outcomes for the patient. These data is also utilized healthcare payers to assess and manage reimbursement policies and check the risks associated with it. Population health management improves the management of patient care as it helps to enhance patient communication, care coordination, and risk stratification.

Healthcare providers is the dominant segment in the population health management market as these solutions helps in better disease management and enhance patient outcomes. This results in decreasing the number of hospital days for patient and reduces the required physician hours, thus helping physicians concentrate on patient-centric care. Population health management also help healthcare payers with implementation of value-based reimbursement by aiding in interpretation of population behaviour and analyse unstructured clinical content.

There is an increase in preference for value-based reimbursement and patient-centric healthcare. As per the value-based reimbursement policies, the healthcare buyers and payers hold the healthcare delivery systems responsible to improve the patient outcome by providing better quality patient care. The increase in the patient data and increase in the prevalence of chronic diseases have led to an increase in the complexity of clinical needs, care delivery, and payment models. This has resulted in the increased demand for population health management programs with multiple functionality to deal with the operational, clinical, and financial data and enhance patient care.

The rise in healthcare expenditure globally, the increase in incidence of chronic diseases, the growing need for effective disease management further drives the growth of global population health management market. However, the lack of proper regulatory framework for population health management are expected to hamper the market growth.

The Visiongain report analyst commented “The increased demand for patient-centric care and implementation of value-based reimbursement have led to the need for better management and analysis of patient data. The increase in incidence of chronic diseases, need for better disease management, and rise in healthcare expenditure further drives the growth of the population health management market”.

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Cerner Corporation, Epic Systems Corporation, Koninklijke Philips, I2I Population Health, Health Catalyst, Optum, Enli Health Intelligence, Eclinicalworks, Allscripts Healthcare Solutions, and IBM Corporation.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.

03 December 2020

Read

Visiongain Publishes Drugs of Abuse Testing Market Report 2021-2031

Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

03 December 2020

Read

Visiongain Publishes Controlled Substance Market Report 2021-2031

Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.

03 December 2020

Read

Visiongain Publishes Companion Animal Diagnostics Market Report 2021-2031

All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.

03 December 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever